Epirubicin and docetaxel with or without capecitabine as neoadjuvant treatment for early breast cancer: final results of a randomized phase III study (ABCSG-24)
Titel:
Epirubicin and docetaxel with or without capecitabine as neoadjuvant treatment for early breast cancer: final results of a randomized phase III study (ABCSG-24)
Auteur:
Steger, G.G. Greil, R. Lang, A. Rudas, M. Fitzal, F. Mlineritsch, B. Hartmann, B.L. Bartsch, R. Melbinger, E. Hubalek, M. Stoeger, H. Dubsky, P. Ressler, S. Petzer, A.L. Singer, C.F. Muss, C. Jakesz, R. Gampenrieder, S.P. Zielinski, C.C. Fesl, C. Gnant, M.